Get startedLog in
    Picture of Illumina logo

    ILMN — Illumina Cashflow Statement

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousLarge CapNeutral
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for Illumina, fiscal year end - December 28th, USD millions except per share, conversion factor applied.

    2022
    January 2nd
    2023
    December 31st
    2023
    January 1st
    2024
    December 29th
    2025
    December 28th
    Period Length:12 M12 M12 M12 M12 M
    Source:10-K10-K10-K10-KPRESS
    Standards:
    USG
    USG
    USG
    USG    		—
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line762-1,161-4,404-1,223—
    Depreciation
    Amortisation
    Deferred Taxes
    Non-Cash Items-2401,3304,2212,301—
    Unusual Items
    Other Non-Cash Items
    Changes in Working Capital-152-90204-4831,079
    Change in Accounts Receivable
    Change in Inventories
    Change in Prepaid Expenses
    Change in Other Assets
    Change in Accounts Payable
    Change in Accrued Expenses
    Change in Other Liabilities
    Net Change in Other Assets & Liabilities
    Other Operating Cash Flow
    Cash from Operating Activities5454783928371,079
    Capital Expenditures-208-196-466-128—
    Purchase of Fixed Assets
    Purchase / Acquisition of Intangibles
    Other Investing Cash Flow Items-861-35-125-50-55
    Acquisition of Business
    Sale of Business
    Sale/Maturity of Investment
    Change in Net Investments
    Purchase of Investments
    Sale of Intangible Assets
    Other Investing Cash Flow
    Cash from Investing Activities-1,069-231-591-178-55
    Financing Cash Flow Items-582-42-54-1,001-744
    Other Financing Cash Flow
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities-51-1,2101,000-570-744
    Foreign Exchange Effects
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash-578-96377979291